Zobrazeno 1 - 9
of 9
pro vyhledávání: '"L C, Fernández Lisón"'
Autor:
C, Cisneros-Serrano, M, Jorge Rial, A, Gómez-Bastero-Fernández, J, Manuel Igea, A, Martínez-Meca, L C, Fernández-Lisón, V, López-Carrasco, E, Villamañán-Bueno, M J, Plá-Martí, E, Chiner
Publikováno v:
Revista Clínica Española (English Edition). 223:154-164
Biologic therapies are known to reduce exacerbations and improve severe uncontrolled asthma management. The at-home administration of biologics has increased during the COVID-19 pandemic, but the characteristics of severe uncontrolled asthma patients
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 36(5)
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 35(4)
The objective is to describe the resistance mutation rate in protease and reverse transcriptase genes and sensitivity to different antiretrovirals in our environment.We performed an observational descriptive study in which we examined the samples pro
Autor:
R, Morillo Verdugo, L C, Fernández Lisón, M J, Huertas Fernández, M T, Martín Conde, J C, Roldan Morales, R, Ruano Camps, J I, Serrano López De Las Hazas, O, Ibarra Barrueta, A, Illaro Uranga
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 34(5)
At present, the side effects associated with antiretroviral treatment are the main reasons for discontinuation of this kind of therapy, both in clinical trials and in regular clinical practise. On the other hand, due to the change of direction that o
Autor:
M T, Garrido Martínez, M, Aguayo Canela, J, Herrera Carranza, I, Chaparro Moreno, M, Ynfante Ferrus, J A, de la Rosa Báez, L C, Fernández Lisón
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 32(5)
To investigate the prevalence of low-molecular-weight heparin (LMWH) prescription in venous thromboembolism prophylaxis in a general hospital and the suitability of the recommendations from the clinical practice guidelines.A descriptive, observationa
Autor:
L C, Fernández Lisón, B, Vázquez Domínguez, J, Luis Fernández, P, Moreno Alvarez, I, Fruns Giménez, J, Liso Rubio
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 32(3)
To assess the quality of life of patients with rheumatoid arthritis undergoing out-patient treatment with TNF inhibitors (etanercept and adalimumab).Observational, descriptive and multi-centre study. A specific validated questionnaire was used (QOL-R
Autor:
L C, Fernández Lisón, B, Vázquez Domínguez, F J, Rodríguez Gómez, A, Hevia Alonso, E, Pujol de la Llave
Publikováno v:
Anales de medicina interna (Madrid, Spain : 1984). 23(12)
Describe the efficacy and safety of tenofovir.Observational, descriptive study. Data were analyzed for the intention-to-treat sample. The primary efficacy end-point included the proportion of patients with HIV-1 RNA level of 50 copies/ml or less. Sec
Autor:
L C, Fernández Lisón, B, Barón Franco, B, Vázquez Domínguez, T, Martínez García, J J, Urendes Haro, E, Pujol de la Llave
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 30(5)
To detect and describe medication errors and adherence to therapy in polymedicated (5 drugs) elderly patients (65 years).A descriptive, observational study using a phone survey to polymedicated elderly outpatients. Sociodemographic, clinical, and pha
Autor:
L C, Fernández Lisón, E, Pujol de la Llave, A, Hevia Alonso, M T, Garrido Martínez, C, Bocanegra Martín
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 29(1)
To assess tenofovir + lamivudine + efavirenz versus zidovudine + lamivudine + efavirenz in treatment-naive patients using a cost-effectiveness analysis.A decision tree was designed. Effectiveness was estimated from clinical trials. Viral load and CD4